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Forkhead Box P3 (Foxp3)-expressing regulatory T
(Treg) cells are central to maintaining self-tolerance
and immune homeostasis. How Treg cell function
and Foxp3 expression are regulated is an important
question under intensive investigation. Here, we
have demonstrated an essential role for the tran-
scription factor GATA-3, a previously recognized
Th2 cell master regulator, in controlling Treg cell
function. Treg cell-specific GATA-3 deletion led to a
spontaneous inflammatory disorder in mice. GATA-
3-null Treg cells were defective in peripheral homeo-
stasis and suppressive function, gained Th17 cell
phenotypes, and expressed reduced amounts of
Foxp3. In addition, GATA-3 controlled Foxp3 expres-
sion by binding to and promoting the activity of
cis-acting elements of Foxp3. Furthermore, the com-
bined function of GATA-3 and Foxp3 was essential
for Foxp3 expression. These findings provide in-
sights into immune regulatory mechanisms and
uncover a critical function of GATA-3 in Treg cells
and immune tolerance.
INTRODUCTION
Regulatory T (Treg) cells are a CD4+ T cell subset possessing
potent immune-suppressive activities critical for maintaining
self-tolerance and immune homeostasis. Defects in Treg cell
function invariably result in autoimmunity and inflammatory
disease in mammals (Sakaguchi et al., 2008; Shevach, 2000).
Foxp3, an X-linked transcription factor, is highly and specifically
expressed in Treg cells. Ectopic expression of Foxp3 endows
non-Treg cells with immune-suppressive function (Brunkow
et al., 2001; Khattri et al., 2003), and Foxp3 deficiency leads to
systemic autoimmune syndrome in human IPEX patients and
Scurfy mice because of lack of functional Treg cells (Brunkow
et al., 2001; Fontenot et al., 2003; Hori et al., 2003; Wildin
et al., 2001). Therefore, Foxp3 is recognized as the central
regulator of Treg cells. To understand immune tolerance and
immune homeostasis, how Treg cell and Foxp3 function are
controlled is a critical question yet to be fully addressed.
Increasing numbers of transcription factors are shown to beImimportant for Treg cell function (Chaudhry et al., 2009; Kerdiles
et al., 2010; Kitoh et al., 2009; Koch et al., 2009; Ouyang et al.,
2010; Rudra et al., 2009; Zheng et al., 2009). Curiously, factors
controlling the differentiation of Th1 and Th2 cells regulate
distinct and specific functions of Treg cells (Kitoh et al., 2009;
Koch et al., 2009; Rudra et al., 2009; Szabo et al., 2000; Zheng
et al., 2009).
GATA-3 is a transcription factor that is highly expressed in Th2
cells and critical for the differentiation of these cells (Zheng and
Flavell, 1997; Zhu et al., 2004). GATA-3 is therefore regarded as
the ‘‘master regulator’’ for Th2 cells. Nevertheless, GATA-3
expression and function is not limited to Th2 cells. GATA-3 is ex-
pressed in multiple tissues and cell types (Yamamoto et al.,
1990) and is required for T cell development and natural killer
(NK) cell function (Pai et al., 2003; Samson et al., 2003). Thus,
GATA-3 plays multifaceted roles of regulating immune function
in a cell-type-specific fashion. Importantly, whether and how
GATA-3 is involved in controlling Treg cell function in vivo is
unknown.
We found that GATA-3 expression was elevated in Treg cells
compared to conventional T cells and was suppressed in Treg
cells under Th1 cell polarizing condition, where Treg cell func-
tion is often found tempered (Caretto et al., 2010; Oldenhove
et al., 2009). We therefore hypothesized that GATA-3 expres-
sion in Treg cells is important for their optimal function and
that defective GATA-3 expression will alter the properties of
Treg cells. To test this hypothesis, we deleted GATA-3 specifi-
cally in Foxp3-expressing Treg cells and found that GATA-3
deletion in Treg cells led to the development of an inflammatory
disorder in mice. GATA-3-deficient Treg cells were intrinsically
defective in their homeostasis and showed compromised
immune-suppressive function in vitro and in vivo. In agreement
with these observations, GATA-3-deficient Treg cells ex-
pressed decreased amounts of Foxp3 and Treg cell ‘‘signature
genes’’ and increased amounts of effector cytokines. In addi-
tion, we demonstrated that GATA-3 bound to the regulatory
region of Foxp3 locus and promoted the activity of a cis-acting
element of Foxp3 gene. Moreover, we showed that the com-
bined function of GATA-3 and Foxp3 was vital for Foxp3
expression, because virtually no Foxp3-expressing cells could
be detected when both GATA-3 and Foxp3 were defective.
Collectively, this study reveals an essential function of GATA-3
in controlling Treg cell function and Foxp3 expression. It pro-
vides further insight into immune regulatory mechanisms and
sheds light on GATA-3 function and how immune responses
are controlled.munity 35, 337–348, September 23, 2011 ª2011 Elsevier Inc. 337
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GATA-3 Controls Treg Cell FunctionRESULTS
Mice with Treg Cell-Specific GATA-3 Deletion
Develop an Inflammatory Disorder
Transcription factors critically involved in directing the differenti-
ation of Th1 and Th2 cells were recently shown to play unique
and important roles in controlling Treg cell function (Kitoh
et al., 2009; Koch et al., 2009; Rudra et al., 2009; Zheng et al.,
2009). However, whether the Th2 cell master regulator GATA-3
is involved in Treg cell function remains unknown. To address
this question, we first asked whether GATA-3 is expressed by
Treg cells. GATA-3 expression was assessed in purified Treg
cells and non-Treg CD4+ T (Tn) cells isolated from FIR mice,
where Foxp3-expressing cells were marked by the expression
of a red fluorescence protein, as described previously (Wan
and Flavell, 2005). Treg cells expressed more GATA-3 than Tn
cells at both mRNA and protein levels. In addition, GATA-3
expression was downregulated in Treg cells under Th1 cell polar-
izing condition associating with reduced Treg cell recovery and
Foxp3 expression (see Figure S1 available online), agreeing
with the finding that Treg cell function is tempered during Th1
cell response (Caretto et al., 2010; Oldenhove et al., 2009). These
observations suggest a potential role of GATA-3 in regulating
Treg cell function. We therefore investigated how GATA-3 is
involved in Treg cell function. To do this, we generated Treg
cell-specific GATA-3-deficient mice by crossing Gata3fl/fl mice
(Amsen et al., 2007) with mice bearing a BAC transgene encod-
ing both enhanced green fluorescence protein (EGFP) and Cre
recombinase under the control of Foxp3 promoter (Foxp3-
EGFP-cre mice [Zhou et al., 2008], hereafter referred to as
FGC mice). In FGC mice, EGFP expression faithfully marks
Foxp3-expressing Treg cells, and Cre-mediated gene deletion
occurs specifically in Treg cells (Zhou et al., 2008).
Although Gata3fl/fl:FGCmice were born normally and matured
to adulthood, they spontaneously developed lymphadenopathy
and splenomegaly by 16 weeks of age (data now shown). In
agreement with this observation, the total numbers of lympho-
cytes recovered from the peripheral lymph nodes (PLN) and
spleens of Gata3fl/fl:FGC mice were higher compared to those
from Gata3fl/+:FGC littermates (Figure 1A), although the distribu-
tion of T cell populations in the thymus, spleen, and peripheral
lymph nodes was normal and Treg cells were generated in the
thymus inGata3fl/fl:FGCmice (Figure S1). In addition, histological
analysis revealed dramatically increased lymphocytic infiltration
in the nonlymphoid organs, such as the lung, pancreas, lacrimal
glands, and salivary glands of Gata3fl/fl:FGC mice (Figure 1B),
suggesting aberrant immune activation. We thus examined the
activation and differentiation status of T cells from Gata3fl/fl:FGC
mice. CD4+ Tn and CD8+ T cell populations with an activated
phenotype (CD62LloCD44hi) were increased in Gata3fl/fl:FGC
mice compared to those in Gata3fl/+:FGC littermates (Figures
1C and S1). In addition, interferon-g (IFN-g), interleukin-4 (IL-4),
and IL-17A production by CD4+ Tn cells were increased in
Gata3fl/fl:FGC mice compared to Gata3fl/+:FGC littermates
(Figures 1D and 1E). Similarly, CD8+ T cells from Gata3fl/fl:FGC
mice produced increased amounts of IFN-g (Figure S1). There-
fore, Treg cell-specific GATA-3 deletion led to an inflammatory
disorder in mice, associated with elevated activation and
effector function of T cells.338 Immunity 35, 337–348, September 23, 2011 ª2011 Elsevier Inc.Treg Cells Lacking GATA-3 Are Defective
in Homeostasis
We then investigated how the Treg cell population was affected
by GATA-3 deletion. First, efficient and specific deletion of
GATA-3 in Treg cells purified from Gata3fl/fl:FGC mice was con-
firmed (Figure 2A). Initial characterization showed that the
numbers of Treg cells were not decreased but moderately
increased in Gata3fl/fl:FGC mice (Figure 2B). Nevertheless, this
observation could be confounded by the inflammatory condi-
tions existed in these mice because Treg cell numbers may be
abnormally upregulated in the hosts with inflammation (Kitoh
et al., 2009; Liu et al., 2008; Rudra et al., 2009).
We therefore compared the ability of GATA-3-deficient and
GATA-3-sufficient Treg cells to repopulate the periphery in the
same host. To this end, we generated mixed bone marrow
chimera by transferring a mixture of bone marrow cells from
Gata3fl/fl:FGC mice bearing congenic marker CD45.2 and
Gata3fl/+:FGCmice bearing congenic marker CD45.1 into irradi-
ated recipient mice deficient in recombination-activating gene 1
(Rag1/). All chimeric mice were grossly normal and showed no
signs of inflammatory disorder (data not shown). Accordingly, in
the chimeric mice, CD4+ Tn and CD8+ T cells of both donor
origins showed naive phenotype with minimal production of
effector cytokines (Figure S2). Although total CD4+ T cells were
derived equally from both donors, the majority (70%–80%) of
Foxp3+ Treg cells were derived from GATA-3-sufficient donor.
And only approximately 20% of Treg cells were derived from
GATA-3-deficient donor (Figure 2C), suggesting an intrinsic
defect in the homeostasis of GATA-3-deficient Treg cells. To
confirm that GATA-3-deficient Treg cells were indeed defective
in homeostasis in the periphery, we purified Treg cells from
Gata3fl/fl:FGC (CD45.2+) and Gata3fl/+:FGC (CD45.1+) mice by
fluorescence-activated cell sorting (FACS). Sorted cells were
mixed at 1:1 ratio and then transferred into Rag1/ mice. Eight
weeks after transfer, the contributions of different donor cells
to Foxp3+ Treg cell populations in the hosts were assessed.
GATA-3-deficient Treg cells were much less abundant than
GATA-3-sufficient counterparts (Figure 2D). Collectively, these
findings suggest that GATA-3-deficient Treg cells are intrinsically
defective in the homeostasis.
Immune-Suppressive Activity Is Impaired
in Treg Cells Lacking GATA-3
We investigated what functions of Treg cells were affected
by GATA-3 deletion. The defining properties of Treg cells are
being unresponsive to T cell receptor (TCR) stimulation (anergy)
in vitro and being able to suppress CD4+ Tn cell function in vivo
and in vitro (Sakaguchi, 2004). We found that GATA-3-deficient
Treg cells remained anergic to TCR stimulation, because Treg
cells from Gata3fl/fl:FGC mice did not proliferate in response to
TCR stimulation in culture (Figure 3A). We then studied whether
the immune-suppressive activity of GATA-3-deficient Treg cells
was affected in vivo by using an inflammatory bowel disease
(IBD) model induced by transferring naive CD4+ cells into SCID
mice (Powrie et al., 1993). Transferring wild-type naive
(CD25CD45RBhi) CD4+ T cells alone elicited IBD in Rag1/
recipient micemanifested by progressive weight loss (Figure 3B).
Cotransferwithwild-typeTregcellswasable toprevent theweight
loss (Figure 3B). In contrast, cotransfer with GATA-3-deficient
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Figure 1. GATA-3 Deletion in Treg Cells
Leads to an Inflammatory Disorder in Mice
(A) The numbers of lymphocytes in the PLN and
spleens from Gata3fl/fl:FGC and Gata3fl/+:FGC
littermates. Data are means ± SD of five mice. *p <
0.05.
(B) Histological analysis of lymphocytic infiltration
in the lung, pancreas, lacrimal gland, and salivary
gland of indicated mice by H&E staining.
(C) Expression of CD44 and CD62L on CD4+
Foxp3 (Tn) cells from the lymph nodes and
spleens of Gata3fl/fl:FGC mice and Gata3fl/+:FGC
littermates. Number in each quadrant showed the
percentage of each population. Data represent at
least four independent experiments.
(D) IFN-g, IL-4, and IL-17 expression by CD4+
Foxp3 (Tn) cells from the PLNs of Gata3fl/fl:FGC
mice and Gata3fl/+:FGC littermates. Number in
each quadrant showed the percentage of each
population. Results are representative of at least
four experiments.
(E) Relative mRNA expression amounts of IFN-g,
IL-4, and IL-17A in sorted CD4+GFP Tn cells from
Gata3fl/fl:FGC mice and Gata3fl/+:FGC littermates.
Means ± SD of triplicates done in one experiments
representative of three are shown.
See also Figure S1.
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GATA-3 Controls Treg Cell FunctionTreg cells failed to stop naive T cell-elicited weight loss in the
recipient mice (Figure 3B). This observation could be due to
reduced numbers of GATA-3-deficient Treg cells in the recipient
mice and/or defective suppressive activity of these cells. Further
examination revealed that the numbers of Foxp3+ GATA-3-defi-
cient Treg cells recovered from the recipient mice were much
lower than those of wild-type Treg cells (Figure 3C). To directly
assess immune-suppressive activity of GATA-3-deficient Treg
cells, we used an in vitro suppression assay and found thatImmunity 35, 337–348, SeGATA-3-deficient Treg cells showed
impaired ability to suppress TCR-stimu-
lated proliferation of coexisting CD4+ Tn
cells (Figure 3D). Therefore, GATA-3 was
required for intact immune-suppressive
activities of Treg cells in vivo and in vitro.
GATA-3-Deficient Treg Cells
Gain the Ability to Produce
Th17 Cytokines
Treg cells normally do not produce
effector cytokines. However, perturba-
tion of Treg cell function often leads to
aberrant cytokine production by these
cells (Gavin et al., 2007; Kitoh et al.,
2009; Oldenhove et al., 2009; Ouyang
et al., 2010; Wan and Flavell, 2007). Our
finding that GATA-3 deletion resulted in
defective Treg cell function prompted us
to ask whether GATA3-deficient Treg
cells produced proinflammatory cyto-
kines. Although freshly isolated GATA-3-
deficient Treg cells produced minimalamounts of IFN-g and IL-4, more than 3% of these cells
produced IL-17A, a defining cytokine for Th17 cells (Harrington
et al., 2005; Park et al., 2005). At least 3-fold more IL-17A was
produced by GATA-3-deficient than -sufficient Treg cells at
both mRNA and protein levels (Figures 4A and 4B). This aberrant
acquisition of a Th17 cell phenotype fromGATA-3-deficient Treg
cells was even more pronounced in mice afflicted with IBD
(Figures 4C and 4D). Because the inflammatory cytokine IL-6
promotes IL-17A production in activated Foxp3+ Treg cellsptember 23, 2011 ª2011 Elsevier Inc. 339
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B Figure 2. Intrinsic Defects of GATA-3-Defi-
cient Treg Cells in the Peripheral Homeo-
stasis
(A) Efficient GATA-3 deletion specifically in Treg
cells from Gata3fl/fl:FGC mice. CD4+ Tn cells
(CD4+GFP) and Treg cells (CD4+GFP+) were sor-
ted from Gata3fl/+:FGC and Gata3fl/fl:FGC mice.
mRNA and protein expression of GATA-3 in each
population was assessed by qRT-PCR and
immunoblotting, respectively. Results for qRT-
PCR were means ± SD of triplicates done in one
experiment representative of three. Results for
immunoblotting were representative of at least
three experiments.
(B) The percentages of Foxp3+ Treg cells in CD4
T cells from PLNs and spleens of Gata3fl/+:FGC
(open bars) and Gata3fl/fl:FGC (solid bars) mice.
Means ± SD of four experiments are shown.
(C) Mixed bone marrow chimera were created by
transferring equal numbers of bone marrow cells
from Gata3fl/+:FGC (CD45.1+) and Gata3fl/fl:FGC
(CD45.2+) mice into sublethally irradiated Rag1/
mice. The contributions of cells originated from
Gata3fl/+:FGC (open bars) and Gata3fl/fl:FGC (solid
bars) bone marrow cells to CD4+ T cell and Foxp3+
Treg cell populations in reconstituted hosts were
determined. Means ± SD of six mice from one
experiment representative of two are shown (NS,
nonsignificant; **p < 0.01).
(D) GFP+ Treg cells were sorted fromGata3fl/+:FGC
(CD45.1+) and Gata3fl/fl:FGC (CD45.2+) mice,
mixed at a ratio of 1:1, and then transferred into
Rag1/ mice. Eight weeks after transfer, Foxp3+
Treg cells from different donors were detected by
Foxp3 and CD45 costaining as shown in left plot.
The contributions of each donor origin to Treg cell
population in the recipients were determined.
Means ± SD of five mice from one experiment
representative of two are shown (**p < 0.01).
See also Figure S2.
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GATA-3 Controls Treg Cell Functionin vitro (Xu et al., 2007; Yang et al., 2008), we speculated that IL-6-
driven IL-17A expression would be enhanced in Treg cells with
GATA-3 deletion. Indeed, upon TCR stimulation in the presence
of exogenous IL-6 alone or IL-6 plus transforming growth factor-b
(TGF-b), a notably higher percentage ofGATA-3-deficient Foxp3+
Treg cells produced IL-17A than that of GATA-3-sufficient Treg
cells (Figure 4E). Therefore, GATA-3-deficient Treg cells acquired
enhanced ability to produce Th17 cell cytokines.
The Expression of Foxp3 and Treg Cell Signature Genes
Is Decreased in GATA-3-Deficient Treg Cells
Aforementioned findings suggested that GATA-3 was essential
for Treg cell function and prompted us to investigate which factor
critical for Tregcell functionwasaffectedbyGATA-3deletion.We
first noticed that EGFP expression, which reflected Foxp3
expression at the transcription level in FGC mice, was consis-
tently lower in Treg cells from Gata3fl/fl:FGC mice than from
Gata3fl/+:FGC mice (Figure 5A). To directly assess Foxp3
mRNA expression, we sorted GATA-3-deficient and -sufficient
Treg cells from Gata3fl/fl:FGC and Gata3fl/+:FGC mice, respec-
tively, and detected Foxp3 expression by quantitative reverse
transcriptase-polymerase chain reaction (RT-PCR). Indeed, the340 Immunity 35, 337–348, September 23, 2011 ª2011 Elsevier Inc.amount of Foxp3 mRNA was decreased by approximately 50%
upon GATA-3 deletion (Figure 5B). In addition, the amount of
Foxp3 protein was reduced to a similar extent in GATA-3-defi-
cient Treg cells (Figure 5C). Treg cell signature genes, such as
CD25, CTLA-4, and GITR, are important for Treg cell function
(Sakaguchi, 2004). We then examined whether the expression
of these genes was affected by GATA-3 deletion. Compared to
Treg cells fromGata3fl/+:FGCmice, Treg cells fromGata3fl/fl:FGC
mice consistently expressed less CD25, CTLA-4, and GITR at
bothmRNA and protein levels (Figures 5D and 5E). Similar obser-
vationweremade inmixedbonemarrowchimera thatwas recon-
stituted with bone marrow cells from Gata3fl/fl:FGC mice
(CD45.2+) and Gata3fl/+:FGC mice (CD45.1+) (Figure 5F); GATA-
3-deficient Treg cells expressed less amounts of Foxp3, CD25,
CTLA-4, and GITR than those of GATA-3-sufficient counterparts
in the same host. Therefore, GATA-3 deletion led to reduced
expression of Foxp3 and Treg cell signature genes in Treg cells.
GATA-3 Binds to CNS2 of Foxp3 Locus
and Promotes Its Activity
Foxp3 is central to controlling various aspects of Treg cell func-
tion. The observation that GATA-3 deletion caused a decrease of
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Figure 3. Immune-Suppressive Activity of Treg Cells Is Impaired in the Absence of GATA-3
(A) GATA-3-deficient Treg cells remained anergic in vitro. GFP+ Treg cells were sorted from Gata3fl/fl:FGC (Gata3, dashed line) and Gata3fl/+:FGC (Gata3+, solid
line) mice. As a control, GFPCD4+ Tn (shaded) cells were sorted from Gata3fl/+:FGC mice. Sorted cells were labeled with CFSE and stimulated with soluble
anti-CD3 in the presence of irradiated APC. Cell proliferation was assessed by CFSE dilution 72 hr after TCR stimulation in vitro.
(B) GATA-3-deficient Treg cells failed to suppress T cell function in vivo. Rag1/ mice were transferred with 2 3 105 CD4+CD25CD45RBhi T cells sorted from
wild-type C57BL/6 mice alone (dotted line) or together with 13 105 of GFP+ Treg cells sorted from Gata3fl/fl:FGCmice (dashed line) or from Gata3fl/+:FGCmice
(solid line). Body weight of recipient mice was monitored weekly for 8 weeks after transfer. The percentage of body weight change was calculated and plotted.
Means ± SEM of five mice in one experiment representative of two are shown (**p < 0.01).
(C) The percentages (indicated by the numbers above the brackets) of Foxp3+ Treg cells in CD4+ T cells recovered from the peripheral lymph nodes (PLN),
mesenteric lymph nodes (MLN), and spleens of recipient mice were determined at the end of experiments described in (B). Means ± SD of five mice in one
experiment representative of two are shown.
(D) GATA-3-deficient Treg cells were defective in suppressing T cell function in vitro. CD4+CD25CD45RBhi responder T (Tresp.) cells were sorted fromwild-type
C57BL/6 mice and labeled with CFSE. Labeled responder T cells were then either cultured alone or mixed with varying amounts (as indicated) of GFP+ Treg cells
sorted from Gata3fl/fl:FGC or Gata3fl/+:FGC mice. Cell mixtures were stimulated with soluble anti-CD3 in the presence of irradiated APC. The proliferation of
responder T cells was assessed by CFSE dilution as shown in left plots. The division-index of responder T cells was determined by FlowJo software and plotted
(right). Means ± SD of triplicate done in one experiments representative of two are shown (*p < 0.05).
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Figure 4. Th17 Cytokine Production by GATA-3-Deficient Treg Cells
(A and B) GFP+ Treg cells were purified from Gata3fl/fl:FGC and Gata3fl/+:FGC mice. Protein expression of IFN-g, IL-4, and IL-17A in sorted Treg cells was
assessed by intracellular staining. The numbers in each quadrant indicate the percentage of relevant population. Representative results of at least five exper-
iments are shown (A). Relative mRNA amounts of IL-17A, IL-21, IFN-g, Rorc, and T-bet in sorted Treg cells were determined by qRT-PCR. Means ± SD of
triplicates done in one experiment representative of three are shown (B).
(C and D) At the end of IBD experiment described in Figure 3B, CD4+ T cells were recovered from mesenteric lymph nodes (MLN) and spleens of the recipient
mice. Protein expression of IL-17A and IFN-g in recovered Foxp3+ Treg cells was determined by intracellular staining. Representative results of three experiments
are shown (C). Relative mRNA amounts of IL-17A, IL-21, IFN-g, Rorc, and T-bet in sorted GFP+ Treg cells from the spleens were determined by qRT-PCR.
Means ± SD of triplicates done in one experiment representative of three are shown (D).
(E) GFP+ Treg cells were sorted from Gata3fl/fl:FGC and Gata3fl/+:FGC mice and then stimulated in vitro with anti-CD3 and anti-CD28 in the presence of IL-6
(40 ng/ml) or IL-6 (40 ng/ml) + TGF-b (2 ng/ml). Four days after stimulation, IL-17A production in Foxp3+ cells was assessed. Results representative of three
experiments are shown.
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GATA-3 Controls Treg Cell FunctionFoxp3 expression (Figure 5) prompted us to study the mecha-
nisms by which GATA-3 regulates Foxp3 expression. Although
reduced CD25 expression in GATA-3-deficient Treg cells can
contribute to decreased Foxp3 expression as indicated by the
fact that IL-2 signaling is critical for Foxp3 expression (Fontenot
et al., 2005; Rubtsov et al., 2010), we nonetheless hypothesized
that GATA-3 may also directly regulate Foxp3 expression. With
PROMO, a transcription factor binding site prediction program,
we identified putative GATA-3 binding sites in previously defined342 Immunity 35, 337–348, September 23, 2011 ª2011 Elsevier Inc.Foxp3 regulatory regions (Figure 6A). Four highly conserved non-
coding DNA sequences (CNS) including promoter, CNS1, CNS2,
and CNS3 in Foxp3 locus have been identified (Long et al., 2009;
Zheng et al., 2010). CNS1 is critical for TGF-b-induced Foxp3
expression, CNS2 is important to maintain Foxp3 expression in
thymus-derived Treg cells, and CNS3 acts as a pioneer element
for Foxp3 expression. We first investigated whether GATA-3
bound to these putative sites in Treg cells by performing chro-
matin immunoprecipitation (ChIP) assay. As expected, we found
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Figure 5. Decreased Expression of Foxp3
and Treg Cell Signature Genes in GATA-3-
Deficient Treg Cells
(A) EGFP expression of gated CD4+GFP+ Treg
cells from PLNs and spleens of Gata3fl/fl:FGC
(dashed lines) andGata3fl/+:FGC (solid lines) mice.
Mean fluorescence intensity (MFI) of EGFP is also
shown as means ± SD of the results from three
mice.
(B) Quantitative RT-PCR analysis of Foxp3 mRNA
in CD4+GFP (Tn) and CD4+GFP+ (Treg) cells
sorted from Gata3fl/fl:FGC (solid bars) and
Gata3fl/+:FGC (open bars) mice. Means ± SD of
triplicates done in one experiment representative
of at least four experiments are shown.
(C) Flow cytometric analysis of Foxp3 expression
in CD4+ T cells in PLNs and spleens of
Gata3fl/fl:FGC (dashed lines) and Gata3fl/+:FGC
(solid lines) mice. The percentages of Foxp3+ cells
and MFI of Foxp3 staining in Foxp3+ cells are also
shown.
(D) Relative mRNA amounts of CD25, CTLA-4, and
GITR in GFP+ Treg cells sorted from Gata3fl/fl:FGC
(solid bars) and Gata3fl/+:FGC (open bars) mice.
Means ± SD of triplicates done in one experiments
representative of four are shown.
(E) The expression of CD25, CTLA-4, and GITR on
GFP+ Treg cells from Gata3fl/fl:FGC (dashed lines)
andGata3fl/+:FGC (solid lines)micewere assessed
by flow cytometric analysis. MFIs are shown as
means ± SD of three mice.
(F) At the end of mixed bone marrow chimera
experiments described in Figure 2C, the expres-
sion of Foxp3, CD25, CTLA-4, and GITR in GFP+
Treg cells originated from Gata3fl/fl:FGC (dashed
lines) or Gata3fl/+:FGC (solid lines) donors were
determined by flow cytometric analysis and com-
pared. Results described in this figure are repre-
sentative of at least three experiments unless
stated otherwise.
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GATA-3 Controls Treg Cell Functionenrichment of GATA-3 binding to the Th2 cell locus (positive
control) (Lee et al., 2006) but not the promoter region of Gmpr
gene (negative control). Nuclear lysates prepared from Treg
and CD4+ Tn cells sorted from wild-type mice were subjected
to ChIP analysis. Enrichment of GATA-3 binding to different sites
was determined by quantitative PCR. GATA-3 showed minimal
or no binding to the promoter, CNS1, and CNS3 regions of
Foxp3 locus in both Treg and CD4+ Tn cells (Figure 6B). In
contrast, a dramatic increase of GATA-3 binding to CNS2 was
observed only in Treg cells but not in CD4+ Tn cells, suggesting
that GATA-3 binds to and regulates CNS2 activity to control
Foxp3 expression specifically in Treg cells (Figure 6B). To inves-
tigate whether GATA-3 is able to regulate CNS2 activity, we
utilized luciferase reporter assays. Luciferase reporter con-
structs containing Foxp3 promoter alone or promoter plus
CNS2 (Long et al., 2009) were transfected into Jurkat T cells
together with either a GATA-3-expressing construct or an empty
construct (control). Although GATA-3 expression slightly en-
hanced the activity of Foxp3 promoter in the absence of
CNS2, it greatly promoted the activity of Foxp3 promoter in the
presence of CNS2 (Figure 6C). This activity appeared to require
direct binding of GATA-3, because GATA-3-promoted activityImwas virtually abolished when a substitution mutation of the
GATA-3 binding site in CNS2 was created (Figure 6D). Taken
together, these findings suggest that GATA-3 controls Foxp3
expression through binding to CNS2 to regulate the activity of
cis-acting elements of the Foxp3 gene.
The Combined Function of GATA-3 and Foxp3
Is Essential for Foxp3 Expression
Multiple transcription factors, including Foxp3 itself, were shown
to be important for Foxp3 expression and Treg cell function
(Gavin et al., 2007; Kerdiles et al., 2010; Kitoh et al., 2009;
Ouyang et al., 2010; Rudra et al., 2009; Zheng et al., 2010).
Nevertheless, defects in a single factor rendered incomplete
abrogation of Treg cell population and/or function, suggesting
that transcription factors may act in combination and redun-
dancy to control Foxp3 expression and Treg cell function.
Genome-wide studies to predict transcription factor binding
sites showed that Treg cell-specific genes and Foxp3-depen-
dent genes tend to have binding sites for both GATA-3 and
Foxp3 (Lee et al., 2010), indicating a functional relationship
between GATA-3 and Foxp3 in Treg cells. Because Foxp3 is crit-
ical for its own expression (Gavin et al., 2007; Zheng et al., 2010)munity 35, 337–348, September 23, 2011 ª2011 Elsevier Inc. 343
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Figure 6. GATA-3 Bound to CNS2 of Foxp3 Locus and Promoted Its Activity
(A) An illustration of putative GATA-3 binding sites in the Foxp3 promoter (Pro), CNS1, CNS2, and CNS3. The numbers denote relative positions to the tran-
scription start site. Exons are marked by filled boxes.
(B) ChIP-coupled quantitative PCR analysis of GATA-3 binding to Foxp3 regulatory regions in sorted GFPCD4+ Tn cells and GFP+ Treg cells purified from FGC
mice. Normal IgG and anti-GATA-3 were used for immunoprecipitation assays. Gmpr locus was used as a negative control and Th2 cell locus was used as
a positive control. Enrichment of GATA-3 binding to each locus was determined. Means ± SD of triplicates done in one experiment representative of at least three
are shown.
(C and D) Luciferase reporter assays. Reporter constructs of PGL4-basic, PGL4 linked with Foxp3 promoter (PGL4-Pro), or PGL4 linked with Foxp3 promoter and
CNS2 (PGL4-Pro-CNS2) were transfected into Jurkat T cells together with a GATA-3-expressing plasmid (+) or an empty plasmid () (C). PGL4-Pro-CNS2
reporter constructs containing wild-type CNS2 (WT-CNS2) or containing CNS2 with a substitute mutation of GATA-3 binding site (Gata3mut-CNS2) were
transfected into Jurkat T cells together with a GATA-3-expressing plasmid (+) or an empty plasmid () (D). In (C) and (D), a Renilla luciferase vector (pRL-TK) was
cotransfected as internal controls. Transfected cells were cultured for 36 hr before relative luciferase units were determined. Means ± SD of triplicates done in one
experiment representative of at least three are shown. **p < 0.01.
See also Table S1.
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GATA-3 Controls Treg Cell Functionand we found that GATA-3 was important for Foxp3 expression,
we hypothesized that the combined function of GATA-3 and
Foxp3 is essential to control Foxp3 expression and that defects
in both GATA-3 and Foxp3 would lead to drastic reduction of
Treg cells.
To test this hypothesis, we first investigated whether GATA-3
remained bound to CNS2 of Foxp3 locus in Treg cells isolated
from FILIG mouse, a hypomorphic Foxp3 strain in which Treg
cells express greatly reduced Foxp3 and are marked by EGFP
(Wan and Flavell, 2007). A strong association of GATA-3 to
CNS2 was detected only in Foxp3-expressing Treg cells but
not in CD4+ Tn cells purified from FILIG mice (Figure 7A), sug-
gesting that GATA-3 is involved in Foxp3 expression in FILIG
Treg cells. Indeed, by crossing Gata3fl/fl:FGC mice with FILIG
mice, we found that the numbers of Foxp3-expressing Treg
cells detected in Gata3fl/fl:FGC:FILIG mice were lower than in
Gata3fl/+:FGC:FILIG mice (Figure 7B). A closer examination
revealed an incomplete deletion of GATA-3 in Treg cells purified
from Gata3fl/fl:FGC:FILIG mice (Figure 7C). Thus, Treg cells that344 Immunity 35, 337–348, September 23, 2011 ª2011 Elsevier Inc.remained in Gata3fl/fl:FGC:FILIG mice were ‘‘escapees’’ that
expressed GATA-3. Because the Cre expression reflects en-
dogenous Foxp3 expression in FGC mice (Zhou et al., 2008),
the great reduction of Foxp3 expression in FILIG mice (Wan
and Flavell, 2007) could result in insufficient Cre expression
and thus incomplete deletion of GATA-3 in Gata3fl/fl:FGC:FILIG
mice. To circumvent this pitfall and to achieve efficient deletion
of GATA-3 in FILIG Treg cells, we bred Gata3fl/fl:FILIG mice
with CD4-Cre transgenic mice (Lee et al., 2001) to generate
Gata3fl/fl:CD4cre:FILIG mice. Sufficient numbers of CD4+
T cells were recovered from Gata3fl/fl:CD4cre:FILIG mice. In
addition, efficient deletion of GATA-3 in these cells was con-
firmed (Figure S3). Although more than 20% of GATA-3-
sufficient CD4+ FILIG cells expressed Foxp3, virtually no
GATA-3-deficient CD4+ FILIG cells expressed Foxp3 (Fig-
ure 7D). Therefore, defective function of both GATA-3 and
Foxp3 led to ablation of Treg cells, suggesting that the com-
bined function of GATA-3 and Foxp3 is essential for Foxp3
expression.
fl/+
fl/fl
fl/flfl/+
fl/+ fl/fl
fl/flfl/+
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Figure 7. The Combined Function of
GATA-3 and Foxp3 Was Essential for Foxp3
Expression
(A) ChIP-coupled quantitative PCR analysis of
GATA-3 binding to CNS2 of Foxp3 locus in sorted
GFPCD4+ Tn cells and GFP+ Treg cells from
FILIG mice. Normal IgG and anti-GATA-3 were
used for immunoprecipitation assays. Gmpr locus
was used as a negative control and Th2 cell locus
was used as a positive control. Enrichment of
GATA-3 binding to each locus was determined.
Means ± SD of triplicates done in one experiment
representative of three are shown.
(B) The percentages of Foxp3+ Treg cells in the
CD4+ T cells isolated from PLN and spleens
of Gata3fl/+:FGC:FILIG and Gata3fl/fl:FGC:FILIG
mice. Means ± SD of four mice are shown. **p <
0.01.
(C) GATA-3 expression in GFPCD4+ Tn and GFP+
Treg cells sorted from Gata3fl/+:FGC:FILIG and
Gata3fl/fl:FGC:FILIG mice. mRNA expression of
GATA-3 in sorted cells were assessed by quanti-
tative RT-PCR (left). Means ± SD of triplicates
done in one experiment representative of three are
shown. In addition, protein expression of GATA-3
in sorted cells was assessed by immunoblotting
(right). Results are representative of three experi-
ments.
(D) Foxp3-expressing Treg cells in the PLNs
of Gata3fl/+:CD4cre:FILIG and Gata3fl/fl:CD4cre:
FILIG mice were detected based on GFP and
Foxp3 expression. The percentages of Foxp3+
cells were determined (shown above the brack-
ets). Representative results from at least three
experiments are shown.
See also Figure S3.
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GATA-3 Controls Treg Cell FunctionDISCUSSION
This study revealed an indispensible role of GATA-3 in regulating
Treg cell function and immune tolerance. Deletion of GATA-3
specifically in Treg cells resulted in an inflammatory syndrome
in mice that can be ascribed to defective function of Treg cells.
In addition, we found that GATA-3 controlled Foxp3 expression.
GATA-3-deficient Treg cells expressed reduced amounts of
Foxp3. GATA-3 bound to the regulatory regions of Foxp3 locus
and promoted the activity of cis-acting elements of Foxp3
gene. Moreover, we demonstrated that the combined function
of GATA-3 and Foxp3 was vital for Foxp3 expression in Treg
cells. This study provides insights into the modulation of Treg
cell function and sheds light on how autoimmunity and inflamma-
tory diseases may be controlled.
GATA-3 is a member of GATA-binding protein family consist-
ing of six members (GATA-1 through -6) that interact with theImmunity 35, 337–348, SeGATA DNA sequence. GATA-3 regulates
an array of biological processes including
development, differentiation, and tumori-
genesis (Pandolfi et al., 1995; Pei et al.,
2009). In particular, GATA-3 is critically
involved in immune regulation. GATA-3
is highly expressed by Th2 cells and is
required for Th2 cell differentiation (Zhengand Flavell, 1997; Zhu et al., 2004). In addition, GATA-3 is essen-
tial for T cell development (Pai et al., 2003). Moreover, it is impor-
tant for the function of NK cells (Samson et al., 2003). Therefore,
GATA-3 exerts diverse functions to control immune response in
a cell type-specific manner. Nevertheless, the understanding of
how GATA-3 regulates immune function is far from complete.
Indeed, this study unveiled a function of GATA-3 in controlling
Treg cell function. Such a function of GATA-3 is vital for self-
tolerance and immune homeostasis, because when GATA-3
was deleted in Treg cells, mice spontaneously developed an
inflammatory disorder. This finding can have broad implications.
Th1 cell response is important for clearing pathogens and also
for causing severe autoimmune diseases, situations where
Treg cell function is often tempered (Caretto et al., 2010; Olden-
hove et al., 2009). Th1 cell polarizing condition antagonizes
GATA-3 expression in non-Treg cells (Szabo et al., 2003). Simi-
larly, we found that Th1 cell polarizing condition also triggersptember 23, 2011 ª2011 Elsevier Inc. 345
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GATA-3 Controls Treg Cell Functionthe downregulation of GATA-3 in Treg cells. It is therefore
conceivable that the strong Th1 cell response during pathogen
clearance and inflammation will lead to GATA-3 downregulation
in Treg cells, whichmay in turn contribute to the reduced function
of these cells. In addition, we have demonstrated that GATA-3-
deficient Treg cells showed enhanced ability to produce inflam-
matory cytokines, indicating that GATA-3 downregulation under
inflammatory conditions could allow Treg cells to acquire
effector functions that contribute to inflammation. Our study
therefore suggests that GATA-3 expression in Treg cells is
important for the modulation of Treg cell function and immune
response, and thus needs to be considered in order to fully
understand how protective (to clear pathogen) and pathogenic
(to cause autoimmunity and inflammatory disease) immune
responses are controlled.
Treg cells are central to controlling immune tolerance and
immune homeostasis. Foxp3 is recognized as a single gene
determinant essential for Treg cell function. Perturbations of
Foxp3 expression, even slight, often lead to impaired Treg cell
function and are associated with various inflammatory diseases
and autoimmunity. Therefore, in order to understand immune
tolerance, howFoxp3 transcription is controlled is a critical ques-
tion under intensive investigation. Many factors including Runx-
CBFb complex, NF-kB, Foxp3, FOXO1, and FOXO3 were shown
to be important for Foxp3 expression (Gavin et al., 2007; Kerdiles
et al., 2010; Kitoh et al., 2009; Long et al., 2009; Ouyang et al.,
2010; Rudra et al., 2009; Zheng et al., 2010). Nonetheless, dele-
tion of any one of these genes causes incomplete abrogation of
Foxp3 expression. These findings not only underscore the vital
importance of maintaining certain amounts of Foxp3 expression
but also imply that multiple factors are involved in promoting
Foxp3 expression in a combinatorial and somewhat redundant
manner. Indeed, combined deficiency of certain set of genes,
such as FOXO1 and FOXO3, results in muchmore drastic defect
in Treg cells than any one gene deficiency achieved (Kerdiles
et al., 2010; Ouyang et al., 2010). Similarly, our results demon-
strated that, although impaired function of GATA-3 or Foxp3
alone caused decrease of Foxp3 expression, defects in both
GATA-3 and Foxp3 led to ablation of Foxp3 expression, suggest-
ing that GATA-3 and Foxp3 control Foxp3 expression in combi-
nation. Therefore, although we are investigating how a single
factor is involved in controlling Foxp3 expression, we also need
to consider how different factors function together to control
Foxp3 expression and Treg cell function.
As a transcription factor, GATA-3 exerts its function mainly
through DNA binding. It is therefore likely that cell-type-specific
function of GATA-3 is mediated through its binding to different
sets of loci in different cell types. To support this notion, we
found that, in non-Treg cells, GATA-3 bound to Th2 cell locus
but not Foxp3 locus. However, in Treg cells, GATA-3 bound to
both Th2 cell locus and CNS2 of Foxp3 locus. Interchromosomal
interaction has been proposed to regulate activities of cis-acting
elements on different chromosomes (Spilianakis et al., 2005).
Such interchromosomal interactions may be mediated through
protein complexes containing specific transcription factors.
The observation that GATA-3 bound to both Foxp3 and Th2
cell loci in Treg cells suggests a potential physical interaction
and mutual regulation between Foxp3 and Th2 cell loci in Treg
cells, an issue that warrants further investigation to elucidate346 Immunity 35, 337–348, September 23, 2011 ª2011 Elsevier Inc.the mutual regulation between Th2 and Treg cells. Although we
have found that GATA-3 bound to CNS2 but not CNS1 (a site
modulating Foxp3 expression in TGF-b-induced Treg cells)
(Zheng et al., 2010) of Foxp3 locus in thymic-derived Treg cells,
consensus GATA-3 binding sites were identified in CNS1, sug-
gesting that GATA-3 may be also involved in regulating Foxp3
expression in TGF-b-induced Treg cells. Th2 cell polarizing
condition was shown to antagonize TGF-b-driven Foxp3 expres-
sion and to promote Th9 cell differentiation (Dardalhon et al.,
2008; Veldhoen et al., 2008), a process that may involve
GATA-3 (Mantel et al., 2007). Further investigation is therefore
needed to addresswhether GATA-3 is involved in such a process
by regulating Foxp3 expression through CNS1 activities.
EXPERIMENTAL PROCEDURES
Mice
Foxp3-GFP-Cre (FGC) mice were purchased from Jackson laboratory and
have been backcrossed into C57BL/6 background for more than five genera-
tions. Gata3fl/fl, CD4-Cre, FILIG, Rag1/, and CD45.1 congenic mice were on
C57BL/6 background. All mice were housed and bred in specific-pathogen-
free conditions in the animal facility at the University of North Carolina at
Chapel Hill. All mouse experiments were approved by Institution Animal
Care and Use Committee of the University of North Carolina.
Flow Cytometric Analysis and Cell Sorting
Lymphocytes were isolated from the various organs (as described) of age- and
sex-matched mice of 8–16 weeks of age. Fluorescence-conjugated antibodies
for CD4, CD8, CD25, CD44, CD62L, GITR, CD45.1, CD45.2, IFN-g, IL-4, IL-17A,
Foxp3 (eBioscience), andCTLA-4 (BDBioscience)werepurchased. Surface and
intracellular staining was performed per manufacturer’s protocols. For intracel-
lular cytokine staining, lymphocytes were stimulated with 50 ng/ml of phorobol
12-myristate 13-acetate (PMA) and 1 mMof ionomycin for 3–4 hr in the presence
ofBrefeldinA. Stained cellswere analyzedona LSRII station (BDBiosciences) or
sorted on Moflow cell sorter (Dako cytomation, Beckman Coulter).
In Vitro Cell Proliferation and Suppression Assay
CD4+GFP+ Treg cells (suppressor) and CD4+GFP non-Treg cells (responder)
were sorted. To assess Treg cell proliferation in vitro, 23 104 sorted Treg cells
were labeled with carboxyfluorescein diacetate succinimidyl ester (CFSE)
and stimulated with soluble CD3 antibody (1 mg/ml) in the presence of 1 3
105 irradiated (3000 cGy) T cell-depleted splenocytes as antigen-presenting
cells (APC). Cell proliferation was assessed by CFSE dilution detected by
flow-cytometric analysis 72 hr poststimulation. To assess the efficacy of
Treg cell-mediated immune suppression in vitro, 2 3 104 sorted responder
T cells were labeled with CFSE and mixed with varying amounts (as indicated)
of Treg suppressor cells. Cell mixtures were stimulated with soluble CD3 anti-
body (1 mg/ml) in the presence of 13 105 irradiated (3000 cGy) T cell-depleted
splenocytes as APC. The proliferation of responder cells was assessed by
CFSE dilution detected by flow-cytometric analysis 72 hr poststimulation.
Luciferase Reporter Assay
PGL4-Pro and PGL4-Pro-CNS2 luciferase reporter constructs were kindly
provided by S. Ghosh (Columbia University). Substitution mutation of
GATA-3-binding site at CNS2 was created with Quickchange Mutagenesis
kit (Agilent Technologies). Jurkat T cells were transfected by electroporation
with 5 mg of reporter plasmid together with 5 mg of GATA-3-expressing
plasmids. 1 mg of pRL-TK plasmid was also cotransfected serving as an
internal control. Firefly and Renilla Luciferase activities were determined with
a dual-reporter assay kit (Promega) 36 hr posttransfection.
Adoptive Transfer Assay, Treg Cell-Mediated Protection
of Naive CD4+ T Cell-Elicited IBD Assay, and Bone Marrow
Transplantation Assay
To determine the ability of Treg cells to be maintained in the periphery, GATA-
3-sufficient and GATA-3-deficient CD4+GFP+ Treg cells bearing different
Immunity
GATA-3 Controls Treg Cell FunctionCD45 congenic markers were sorted. 1 3 105 sorted Treg cells were cotrans-
ferred into Rag1/ recipients via retro-orbital injection. The contribution of
each donor to the Treg cell population recovered in the hosts was determined
8 weeks posttransfer. To assess Treg cell-mediated protection of naive T cell-
elicited IBD in vivo, 1 3 105 sorted Treg cells were mixed with 2 3 105 naive
(CD25CD45RBhi) CD4+ T cells sorted from wild-type C57BL/6 mice. Cell
mixture was transferred into Rag1/ via retro-orbital injection. As control,
2 3 105 naive CD4+ T cells were also transferred alone into Rag1/ mice.
Tomonitor IBD development, bodyweight of the recipient micewasmonitored
weekly after the transfer. Recipient mice were euthanized 8 weeks after trans-
fer. T cells from these mice were harvested and subjected to immunological
analysis. To create mixed bone marrow chimera, bone marrow cells were iso-
lated from the femur bones of Gata3fl/fl:FGC or Gata3fl/+:FGC mice bearing
different CD45 congenic markers. 13 106 bone marrow cells from each donor
weremixed and transferred into irradiated (500 cGy)Rag1/mice. The contri-
bution of each donor to Treg cell population in the recipients was determined
8 weeks after transfer.
Chromatin Immunoprecipitation Assay
ChIP assay was performed per Upstate Biotechnology’s protocol. In brief,
cells were cross-linked by 1% formaldehyde and lysed in lysis buffer. The
lysates were sonicated with a Bioruptor sonicator to shear genomic DNA
into 200–500 bp fragments. Chromatin prepared from 2 3 106 CD4+GFP+
Treg cells and CD4+GFP Tn cells were subjected to immunoprecipitation
overnight at 4Cwith goat anti-GATA-3 (D-16, sc-22206, Santa Cruz) or normal
goat IgG (sc-2028, Santa Cruz) antibodies. Quantitative real-time PCR was
performed to determine the relative abundance of target DNA. Specific
primers for analysis of GATA-3 binding to Foxp3 and other target loci are listed
in Table S1.
Statistical Analysis
Data from at least three sets of samples were used for statistical analysis.
Statistical significance was calculated by Student’s t test. A p value of less
than 0.05 was considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and one table and can be
found with this article online at doi:10.1016/j.immuni.2011.08.012.
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